DekaBank Deutsche Girozentrale Has $201,000 Holdings in Option Care Health, Inc. $OPCH

DekaBank Deutsche Girozentrale lessened its stake in Option Care Health, Inc. (NASDAQ:OPCH) by 27.2% in the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 6,380 shares of the company’s stock after selling 2,387 shares during the quarter. DekaBank Deutsche Girozentrale’s holdings in Option Care Health were worth $201,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in the stock. Stephens Inc. AR acquired a new stake in Option Care Health in the 2nd quarter valued at about $317,000. VIRGINIA RETIREMENT SYSTEMS ET Al acquired a new stake in Option Care Health in the 2nd quarter valued at about $348,000. Mutual of America Capital Management LLC increased its position in Option Care Health by 0.4% in the 2nd quarter. Mutual of America Capital Management LLC now owns 161,867 shares of the company’s stock valued at $5,257,000 after acquiring an additional 681 shares in the last quarter. Allianz Asset Management GmbH increased its position in Option Care Health by 378.3% in the 2nd quarter. Allianz Asset Management GmbH now owns 35,871 shares of the company’s stock valued at $1,165,000 after acquiring an additional 28,371 shares in the last quarter. Finally, Bridges Investment Management Inc. increased its position in Option Care Health by 15.4% in the 2nd quarter. Bridges Investment Management Inc. now owns 56,595 shares of the company’s stock valued at $1,838,000 after acquiring an additional 7,564 shares in the last quarter. Institutional investors and hedge funds own 98.05% of the company’s stock.

Option Care Health Stock Down 0.5%

Option Care Health stock opened at $27.91 on Monday. The company’s 50 day simple moving average is $27.99 and its 200 day simple moving average is $30.07. Option Care Health, Inc. has a fifty-two week low of $21.39 and a fifty-two week high of $35.53. The firm has a market capitalization of $4.53 billion, a price-to-earnings ratio of 22.33, a PEG ratio of 1.69 and a beta of 0.88. The company has a debt-to-equity ratio of 0.81, a current ratio of 1.52 and a quick ratio of 1.00.

Option Care Health (NASDAQ:OPCH) last released its quarterly earnings data on Wednesday, July 30th. The company reported $0.41 earnings per share for the quarter, topping the consensus estimate of $0.40 by $0.01. Option Care Health had a net margin of 3.93% and a return on equity of 17.53%. The business had revenue of $1.42 billion for the quarter, compared to analyst estimates of $1.35 billion. During the same quarter last year, the firm earned $0.30 EPS. Option Care Health’s quarterly revenue was up 15.4% compared to the same quarter last year. Option Care Health has set its FY 2025 guidance at 1.650-1.720 EPS. As a group, sell-side analysts anticipate that Option Care Health, Inc. will post 1.22 EPS for the current year.

Insiders Place Their Bets

In related news, Director Timothy P. Sullivan bought 20,000 shares of the company’s stock in a transaction on Thursday, August 21st. The shares were purchased at an average cost of $27.51 per share, for a total transaction of $550,200.00. Following the acquisition, the director owned 49,229 shares of the company’s stock, valued at approximately $1,354,289.79. This represents a 68.43% increase in their position. The purchase was disclosed in a filing with the SEC, which can be accessed through this link. Also, Director Harry M. Jansen Kraemer, Jr. bought 36,000 shares of the company’s stock in a transaction on Wednesday, August 20th. The shares were bought at an average price of $27.15 per share, for a total transaction of $977,400.00. Following the completion of the acquisition, the director directly owned 375,390 shares in the company, valued at approximately $10,191,838.50. This trade represents a 10.61% increase in their position. The disclosure for this purchase can be found here. In the last three months, insiders have purchased 59,411 shares of company stock worth $1,627,576. Company insiders own 0.64% of the company’s stock.

Analyst Ratings Changes

Several research firms have weighed in on OPCH. Morgan Stanley began coverage on shares of Option Care Health in a research report on Friday, October 17th. They issued an “overweight” rating and a $35.00 price objective for the company. Barrington Research reaffirmed an “outperform” rating and issued a $38.00 target price on shares of Option Care Health in a research note on Tuesday, September 23rd. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Option Care Health in a research note on Saturday. Citigroup reaffirmed an “outperform” rating on shares of Option Care Health in a research note on Thursday, July 31st. Finally, TD Cowen initiated coverage on shares of Option Care Health in a research note on Thursday, October 2nd. They issued a “hold” rating and a $30.00 target price on the stock. Nine analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the stock. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average target price of $35.10.

Option Care Health Company Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.